Hepatitis Delta Enters a New Therapeutic Era

J Infect Dis. 2018 Mar 28;217(8):1173-1176. doi: 10.1093/infdis/jix658.

Authors

Vincent Soriano¹, Antonio Aguilera²

Affiliations

¹ Infectious Diseases Unit, La Paz University Hospital, Madrid.
² Microbiology Department, Complexo Hospitalario Universitario Santiago and University of Santiago, Santiago de Compostela, Spain.

PMID: 29425322
DOI: 10.1093/infdis/jix658

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents*
Hepatitis D*
Hepatitis D, Chronic*
Hepatitis Delta Virus
Humans
Interferons

Substances

Antiviral Agents
Interferons